Document is current
Any future updates will be listed below
-
Authors
Manna, Sam
Ortika, Belinda D.
Werren, Joel P.
Pell, Casey L.
Gjuroski, Ilche
Lo, Stephanie W.
Hinds, Jason
Tundev, Odgerel
Dunne, Eileen M.
Gessner, Bradford D.
Russell, Fiona M.
Mulholland, E. Kim
Mungun, Tuya
von Mollendorf, Claire
Bentley, Stephen D.
Hilty, Markus
Ravenscroft, Neil
Satzke, Catherine
-
Funding
Funding for this research was provided by:
Robert Austrian Research Award in Pneumococcal Vaccinology (N/A)
Pfizer (N/A, N/A, N/A, N/A, N/A, N/A, N/A)
National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (GNT1196415, GNT1196415, GNT1196415, GNT1196415, GNT1196415)
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 20 February 2025
First Online: 25 March 2025
Declarations
:
: The 33G-like isolates described in this study were derived from a hospital-based pneumonia surveillance program of adults in Mongolia, which involved collection of nasopharyngeal swabs for pneumococcal detection and serotyping. Further details of the study protocol have been described previously []. Study approval was obtained from the National Ethics Committee for Health Research in Mongolia as well as the Royal Children’s Hospital Human Research Ethics Committee in Australia (HREC number 38045B). Written informed consent was acquired from all participants prior to study enrolment.
: Not applicable.
: CVM, EKM, TM, BDG, and CS are investigators on a clinical research collaboration with Pfizer on PCV vaccination in Mongolia from which the isolates used in this study are derived. Salary support was received through the institutions. CS and EKM are investigators on a Merck Investigator Studies Program grant funded by MSD for a study unrelated to this work. SM, CVM, and CS have received honoraria [Pfizer (CS, SM, and CVM) and MSD (CS)] for presentations at symposia or attendance at expert advisory meetings unrelated to this study. MH is an investigator on a research grant funded by Pfizer for a study unrelated to this work. EMD and BDG are employed by Pfizer and may hold Pfizer stock or stock options. JH is co-founder and shareholder of BUGS Bioscience Ltd., a not-for-profit spin-out company of St George’s, University of London.
